New asthma pill shows promise in major trial

NCT ID NCT03215758

Completed Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study tested whether adding an experimental pill called QAW039 to standard asthma medications could help patients whose asthma is not well controlled. Over 12 weeks, researchers measured if the drug improved lung function, reduced daytime symptoms, and decreased the need for rescue inhalers compared to a placebo. The trial involved 675 adults and adolescents with persistent asthma symptoms despite using their regular controller medications.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Novartis Investigative Site

Flagstaff, Arizona, 86001, United States
Novartis Investigative Site

Phoenix, Arizona, 85006, United States
Novartis Investigative Site

Huntington Beach, California, 92647, United States
Novartis Investigative Site

Long Beach, California, 90808, United States
Novartis Investigative Site

Los Angeles, California, 90025, United States
Novartis Investigative Site

Mission Viejo, California, 92691, United States
Novartis Investigative Site

Mountain View, California, 94040, United States
Novartis Investigative Site

Orange, California, 92868, United States
Novartis Investigative Site

Roseville, California, 95661, United States
Novartis Investigative Site

Walnut Creek, California, 94598, United States
Novartis Investigative Site

Denver, Colorado, 80206, United States
Novartis Investigative Site

Tamarac, Florida, 33321, United States
Novartis Investigative Site

Winter Park, Florida, 32789, United States
Novartis Investigative Site

Albany, Georgia, 31707, United States
Novartis Investigative Site

Dacula, Georgia, 30019, United States
Novartis Investigative Site

Honolulu, Hawaii, 96814, United States
Novartis Investigative Site

Lihue, Hawaii, 96766, United States
Novartis Investigative Site

Overland Park, Kansas, 66210, United States
Novartis Investigative Site

Louisville, Kentucky, 40215, United States
Novartis Investigative Site

Columbia, Missouri, 65203, United States
Novartis Investigative Site

Rolla, Missouri, 65401, United States
Novartis Investigative Site

Missoula, Montana, 59808, United States
Novartis Investigative Site

Bellevue, Nebraska, 68123, United States
Novartis Investigative Site

La Vista, Nebraska, 68128, United States
Novartis Investigative Site

Skillman, New Jersey, 08558, United States
Novartis Investigative Site

Asheville, North Carolina, 28801, United States
Novartis Investigative Site

Gastonia, North Carolina, 28054, United States
Novartis Investigative Site

High Point, North Carolina, 27262, United States
Novartis Investigative Site

Cincinnati, Ohio, 45231, United States
Novartis Investigative Site

Edmond, Oklahoma, 73034, United States
Novartis Investigative Site

Eugene, Oregon, 97401-4043, United States
Novartis Investigative Site

Medford, Oregon, 97504, United States
Novartis Investigative Site

Portland, Oregon, 97213, United States
Novartis Investigative Site

Portland, Oregon, 97220, United States
Novartis Investigative Site

Rapid City, South Dakota, 57701, United States
Novartis Investigative Site

Boerne, Texas, 78006, United States
Novartis Investigative Site

Dallas, Texas, 75231, United States
Novartis Investigative Site

El Paso, Texas, 79903, United States
Novartis Investigative Site

Fort Worth, Texas, 76109, United States
Novartis Investigative Site

McKinney, Texas, 75069, United States
Novartis Investigative Site

Seattle, Washington, 98122-4379, United States
Novartis Investigative Site

Greenfield, Wisconsin, 53228, United States
Novartis Investigative Site

Berazategui, Buenos Aires, 1888, Argentina
Novartis Investigative Site

CABA, Buenos Aires, C1056ABJ, Argentina
Novartis Investigative Site

CABA, Buenos Aires, C1122AAK, Argentina
Novartis Investigative Site

CABA, Buenos Aires, C1425BEN, Argentina
Novartis Investigative Site

CABA, Buenos Aires, C1426ABP, Argentina
Novartis Investigative Site

Lanús, Buenos Aires, B8000XAV, Argentina
Novartis Investigative Site

Mar del Plata, Buenos Aires, 7600, Argentina
Novartis Investigative Site

Santa Rosa, La Pampa Province, 6300, Argentina
Novartis Investigative Site

Buenos Aires, Nueve De Julio, B6500BWQ, Argentina
Novartis Investigative Site

Santa Fe, Rosario, S2000DBS, Argentina
Novartis Investigative Site

Rosario, Santa Fe Province, S2000BRH, Argentina
Novartis Investigative Site

Rosario, Santa Fe Province, S2000JKR, Argentina
Novartis Investigative Site

San Miguel de Tucumán, Tucumán Province, 4000, Argentina
Novartis Investigative Site

San Miguel de Tucumán, Tucumán Province, T4000IFL, Argentina
Novartis Investigative Site

Buenos Aires, C1012AAR, Argentina
Novartis Investigative Site

Buenos Aires, C1125ABE, Argentina
Novartis Investigative Site

Córdoba, X5003DCE, Argentina
Novartis Investigative Site

Mendoza, 5500, Argentina
Novartis Investigative Site

Mendoza, M5500CBA, Argentina
Novartis Investigative Site

Salta, 4000, Argentina
Novartis Investigative Site

Peine, Lower Saxony, 31224, Germany
Novartis Investigative Site

Cottbus, Saxony, 03050, Germany
Novartis Investigative Site

Aschaffenburg, 63739, Germany
Novartis Investigative Site

Bamberg, 96049, Germany
Novartis Investigative Site

Berlin, 12157, Germany
Novartis Investigative Site

Berlin, 12203, Germany
Novartis Investigative Site

Fürstenwalde, 15517, Germany
Novartis Investigative Site

Gauting, 82131, Germany
Novartis Investigative Site

Leipzig, 04275, Germany
Novartis Investigative Site

Lübeck, 23552, Germany
Novartis Investigative Site

Prien A Chiemsee, 83209, Germany
Novartis Investigative Site

Rüdersdorf, 15562, Germany
Novartis Investigative Site

Schleswig, 24837, Germany
Novartis Investigative Site

Schwerin, 19055, Germany
Novartis Investigative Site

Witten, 58452, Germany
Novartis Investigative Site

Budaörs, HUN, 2040, Hungary
Novartis Investigative Site

Ajka, 8400, Hungary
Novartis Investigative Site

Budapest, 1125, Hungary
Novartis Investigative Site

Debrecen, 4032, Hungary
Novartis Investigative Site

Gödöllő, 2100, Hungary
Novartis Investigative Site

Szeged, 6722, Hungary
Novartis Investigative Site

Culiacán, Sinaloa, 80230, Mexico
Novartis Investigative Site

Río de Janeiro, 06700, Mexico
Novartis Investigative Site

Lipa City, Batangas, 4217, Philippines
Novartis Investigative Site

Quezon City, Manila, 1100, Philippines
Novartis Investigative Site

Iloilo City, 5000, Philippines
Novartis Investigative Site

Manila, 1000, Philippines
Novartis Investigative Site

Riyadh, SAU, 11525, Saudi Arabia
Novartis Investigative Site

Jeddah, 21423, Saudi Arabia
Novartis Investigative Site

Bardejov, Slovak Republic, 085 01, Slovakia
Novartis Investigative Site

Kežmarok, 060 01, Slovakia
Novartis Investigative Site

Michalovce, 071 01, Slovakia
Novartis Investigative Site

Poprad, 058 01, Slovakia
Novartis Investigative Site

Prešov, 080 01, Slovakia
Novartis Investigative Site

Spišská Nová Ves, 052 01, Slovakia
Novartis Investigative Site

Žilina, 01207, Slovakia
Novartis Investigative Site

Tygerberg, Cape Town, 7505, South Africa
Novartis Investigative Site

Cape Town, 7500, South Africa
Novartis Investigative Site

Chatsworth, 4092, South Africa
Novartis Investigative Site

Durban, 4001, South Africa
Novartis Investigative Site

Pretoria, 0183, South Africa
Novartis Investigative Site

Istanbul, TUR, 34098, Turkey (Türkiye)
Novartis Investigative Site

Adana, 01330, Turkey (Türkiye)
Novartis Investigative Site

Ankara, 06100, Turkey (Türkiye)
Novartis Investigative Site

Istanbul, 34020, Turkey (Türkiye)
Novartis Investigative Site

Mersin, 33343, Turkey (Türkiye)
Novartis Investigative Site

Talas / Kayseri, 38039, Turkey (Türkiye)
Novartis Investigative Site

Yenisehir/Izmir, 35110, Turkey (Türkiye)

Conditions

Explore the condition pages connected to this study.

ASTHMA